reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Rein Therapeutics, Inc.

RNTX · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$32Mpublic float
2025-04-17most recent failure

Score over time

0123202220232024202520262024-01-01 · score 12023-10-31 auditor change2024-04-01 · score 22024-01-10 auditor change2023-10-31 auditor change2024-07-01 · score 32024-04-01 filed late (10-K) · acquisition or merger2024-01-10 auditor change2023-10-31 auditor change2024-10-01 · score 32024-04-01 filed late (10-K) · acquisition or merger2024-01-10 auditor change2023-10-31 auditor change2025-01-01 · score 22024-04-01 filed late (10-K) · acquisition or merger2024-01-10 auditor change2025-04-01 · score 22025-03-31 filed late (10-K) · complex accounting2024-04-01 filed late (10-K) · acquisition or merger2025-07-01 · score 22025-04-17 auditor change2025-03-31 filed late (10-K) · complex accounting2025-10-01 · score 22025-04-17 auditor change2025-03-31 filed late (10-K) · complex accounting2026-01-01 · score 22025-04-17 auditor change2025-03-31 filed late (10-K) · complex accounting2026-04-01 · score 12025-04-17 auditor change

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Rein Therapeutics, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete certain processes and procedures to finalize the Form 10-K, including the completion of its assessment of impairment losses on intangible assets for the fiscal year ended December 31, 2024

NT 10-K, filed 2025-03-31 · complex accounting

What it filed

2025-04-17auditor changed or resigned SEC →

2025-03-31filed late (10-K)complex accounting SEC →

Rein Therapeutics, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete certain processes and procedures to finalize the Form 10-K, including the completion of its assessment of impairment losses on intangible assets for the fiscal year ended December 31, 2024

2024-04-01filed late (10-K)acquisition or merger SEC →

Aileron Therapeutics, Inc. (the “Company”) has determined that it is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete technical accounting matters related to the purchase price allocation of its acquisition of Lung Therapeutics, Inc. (the “Lung Acquisition”), which closed on October 31, 2023, and to finalize its financial statements included in the Form 10-K. The closing of the Lung Acquisition was reported on a current report on Form 8-K filed with the Securities and Exchange Commission on October 31, 2023. The Company intends to file the Form 10-K no later than the fifteenth calendar day after the prescribed due date

2024-01-10auditor changed or resigned SEC →

2023-10-31auditor changed or resigned SEC →

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com